Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine - United States, September 6, 2020-May 1, 2021

Throughout the COVID-19 pandemic, older U.S. adults have been at increased risk for severe COVID-19-associated illness and death (1). On December 14, 2020, the United States began a nationwide vaccination campaign after the Food and Drug Administration's Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine. The Advisory Committee on Immunization Practices (ACIP) recommended prioritizing health care personnel and residents of long-term care facilities, followed by essential workers and persons at risk for severe illness, including adults aged ≥65 years, in the early phases of the vaccination program (2). By May 1, 2021, 82%, 63%, and 42% of persons aged ≥65, 50-64, and 18-49 years, respectively, had received ≥1 COVID-19 vaccine dose. CDC calculated the rates of COVID-19 cases, emergency department (ED) visits, hospital admissions, and deaths by age group during November 29-December 12, 2020 (prevaccine) and April 18-May 1, 2021. The rate ratios comparing the oldest age groups (≥70 years for hospital admissions; ≥65 years for other measures) with adults aged 18-49 years were 40%, 59%, 65%, and 66% lower, respectively, in the latter period. These differential declines are likely due, in part, to higher COVID-19 vaccination coverage among older adults, highlighting the potential benefits of rapidly increasing vaccination coverage.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:70

Enthalten in:

MMWR. Morbidity and mortality weekly report - 70(2021), 23 vom: 11. Juni, Seite 858-864

Sprache:

Englisch

Beteiligte Personen:

Christie, Athalia [VerfasserIn]
Henley, S Jane [VerfasserIn]
Mattocks, Linda [VerfasserIn]
Fernando, Robyn [VerfasserIn]
Lansky, Amy [VerfasserIn]
Ahmad, Farida B [VerfasserIn]
Adjemian, Jennifer [VerfasserIn]
Anderson, Robert N [VerfasserIn]
Binder, Alison M [VerfasserIn]
Carey, Kelly [VerfasserIn]
Dee, Deborah L [VerfasserIn]
Dias, Taylor [VerfasserIn]
Duck, William M [VerfasserIn]
Gaughan, Denise M [VerfasserIn]
Lyons, Brianna Casey [VerfasserIn]
McNaghten, A D [VerfasserIn]
Park, Meeyoung M [VerfasserIn]
Reses, Hannah [VerfasserIn]
Rodgers, Loren [VerfasserIn]
Van Santen, Katharina [VerfasserIn]
Walker, David [VerfasserIn]
Beach, Michael J [VerfasserIn]

Links:

Volltext

Themen:

COVID-19 Vaccines
Journal Article

Anmerkungen:

Date Completed 11.06.2021

Date Revised 22.06.2021

published: Electronic

Citation Status MEDLINE

doi:

10.15585/mmwr.mm7023e2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM326590382